Treosulfan
From Wikipedia, the free encyclopedia
|
Treosulfan
|
|
| Systematic (IUPAC) name | |
| (2,3-dihydroxy-4-methylsulfonyloxybutyl) methanesulfonate | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C6H14O8S2 |
| Mol. mass | 278.30056 g·mol−1 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral, IV |
Treosulfan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called alkylating agents.
[edit] External links
- Treosulfan entry in the public domain NCI Dictionary of Cancer Terms
This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms

